Ametris - formerly ActiGraph

08/07/2025

📑 Are you applying for grant funding and using wearables in your study? Check out our new toolkit: Grant Preparation Resources for Wearable-Based Studies!

🔗 is in the comments below!

Our goal with this toolkit is to facilitate the grant application submission process by gathering commonly requested Ametris-related information in one place for quick and convenient access, including -
✔️ Product Resources
✔️ Regulatory Compliance Information
✔️ Support and Warranty Details
✔️ Scientific Evidence

We hope this resource helps to support the important health-related research that actigraphy and wearable DHTs have contributed to!

08/06/2025

🔎 Have you seen the ADDS Basel 2025 agenda yet?

In addition to over 15 presentations and panel discussions across four sessions focused on Neurology, Oncology, Technical Validation and Regulatory Pathways, we scheduled time specifically for collaborative discussions and networking opportunities 🤝

Watch the short video below to hear what makes ADDS such a unique opportunity to bring members of the multidisciplinary digital health community together!

We hope you can join us along with biopharma and academic digital health researchers from Roche, Novartis, University of Oxford, J&J Innovative Medicine, and more to discuss how we can accelerate adoption of DHTs in regulated trials.

Space is limited; make sure to reserve your spot! Review event details and register today using the link in the comment ⤵️

08/05/2025

🎥 Our latest Digital Health Monthly webinar is available on-demand! You can watch Grant Planning for Wearable-Based Research: Insights and Best Practices using the link in the comments.

Our panelists discussed key points and lessons learned based on their experiences writing and reviewing grants that include wearable DHTs to help researchers submit compelling, high-impact proposals.

This informative discussion covered topics like -
🔸 Starting with a strong research question, and then addressing feasibility
🔸 Collecting preliminary data and how you can leverage resources such as open-source data sets
🔸 The use cases for medical-grade and consumer-grade wearables
🔸 Why the logistics of DHT studies matters in your grant application

Thank you to our stellar panelists for joining us and sharing your insights!

✨ Samuel Lamunion, PhD, LRS & C, LLC
✨ Catherine Lang, PT, PhD, FAPTA, Washington University in St. Louis
✨ Sriram Yennu, MD, MS, FAAHPM, The University of Texas MD Anderson Cancer Center
✨ Hayden Davis, Ametris
✨ Rakesh Pilkar, PhD, Ametris

07/30/2025

💡 Wearable data can only generate important insights to help advance clinical research if it’s collected as expected.

This may sound straightforward, but there are many battery life, storage, and connectivity issues that can cause missing data, limiting the potential of your study.

🤔 How can you ensure that you’re collecting the wearable data that you need?

Our Chief Product & Technical Officer, Kim Rejndrup, shares how Ametris is making it as simple as possible to capture wearable DHT data by engaging participants and streamlining information for sites with features like:

✅ Proactive participant notifications available in 20+ languages
✅ An intuitive dashboard to help sites quickly identify and address data collection risks
✅ A prevention-first approach to ensure raw sensor data is captured as planned

Read the full blog to learn how these new features can help you collect wearable DHT data and capture important insights to advance clinical research using the link in the comments 👇

07/25/2025

Last month, we rebranded to Ametris, a transformation that reflects more than just a new name and visual identity. It reflects our company’s evolution from a wearable device manufacturer into a global digital health solutions provider.

Read more about how this rebrand embodies the ways we’ve grown over the years, why this name fits our company so well, and how we’re pioneering the digital transformation of clinical research in this blog from our CEO, Jeremy Wyatt - https://hubs.ly/Q03xWghj0

07/24/2025

We're excited to see Christine Cong Guo, our Chief Scientific Officer, featured in The Medicine Maker, where she discusses how continuous physiological monitoring from digital health technology could improve CRS monitoring to expand patient recruitment for clinical trials and post-market access to immunotherapy.

Read the article here 👉 https://themedicinemaker.com/issues/2025/articles/july/improving-immunotherapies-with-digital-monitoring/

An expert explains how digital technologies are helping to prevent cytokine release syndrome from immunotherapies.

07/23/2025

Patients with Pulmonary Arterial Hypertension (PAH) commonly experience shortness of breath and fatigue that negatively impact their quality of life, often limiting their capacity for physical activity.

📓A recent article shared details from the TRACE study that included digital measures of physical activity from patients with PAH during their everyday life. Key findings from the article -

📊 Actigraphy-derived walking bout measures significantly correlated with 6-min walk distance and the PAH Symptoms and Impact questionnaire

📊 Actigraphy-derived walking bout measures negatively correlated with the Borg dyspnea index

📊 Test-retest reliability for actigraphy-derived physical activity measures was strong across 3 timepoints

📊 Actigraphy-derived measures differentiated well between patients with varying levels of disease severity

This data speaks to the utility of digital measures to provide continuous monitoring of exercise capacity in patients with PAH, helping to address limitations of episodic in-clinic measures to improve monitoring over time and accelerate clinical trial programs. Read the full paper here: https://hubs.ly/Q03xWTJM0

📚 You can also visit our Patient-Focused Digital Measures Library, where we relate the most significant symptoms described by patients to meaningful aspects of health that can be assessed using digital measures, highlighting opportunities for researchers to use data from medical-grade wearable DHTs to support patient-centric drug development for conditions including PAH and more: https://hubs.ly/Q03xX06s0

07/22/2025

📅 We hope you can join us next week for Grant Planning for Wearable-Based Research: Insights & Best Practices on Wednesday, July 30th at 12PM ET - register using the link in the comments!

⌚ Wearable digital health technology is transforming academic, public health, and clinical research, helping to generate important health-related insights. We’ll share practical strategies from pre-study planning through grant submission to real-world study operations, plus answer your questions live.

Don’t miss an inside look at Ametris’ new resources to support your next grant application that includes actigraphy. Register today! 🔗in the comments

Featured Speakers -

🔸Samuel LaMunion, PhD, Principal Consultant, LRS & C, LLC
🔸Catherine Lang, PT, PhD, FAPTA, Professor of Physical Therapy, Neurology & Occupational Therapy, Washington University in St. Louis
🔸Sriram Yennu, MD, MS, FAAHPM, Professor, Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center
🔸Hayden Davis, Senior Director of Public Health and Academia, Ametris
🔸Rakesh Pilkar, PhD, Lead DHT Solutions, Neuroscience, Ametris

07/21/2025

🚨 This is the LAST CALL to submit your abstract to the Scientific Poster Session at ADDS Basel 2025! 🚨

We invite you to submit your abstract for consideration to be included in the poster session no later than 📅 Sunday, July 27, 2025 -
🔹Research must include wearable digital health technology
🔹Abstracts must contain original, unpublished data

This is an exciting opportunity for researchers to discuss the details of their project and network with key thought leaders in the digital health field! Link to submission page is in the comment below ⤵️

🗨️ “Different from other conferences, ADDS provides the space to get into the weeds of device measurements and how to optimize these measures to advance your research,” Sidney Donzella, PhD, MPH, Postdoctoral Fellow, Fred Hutchinson Cancer Center

🗨️ “I would recommend any researcher interested in the use of digital technologies for clinical research to attend ADDS because it allows you to meet like-minded individuals and hear about research from across the world in this field,” Lucy Musson, PhD Student, University of Sheffield

07/17/2025

Ametris is excited to welcome a new Accelerant program partner, Modality. AI, a pioneer in AI-powered audio and visual biomarker technology for the assessment of neurological and psychiatric conditions.

This collaboration enables the remote collection of clinically validated audio and visual biomarkers alongside real-world measures of physical function, sleep, and vital signs for a holistic view of participant function in clinical trials developing new treatments for conditions such as amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.

The strategic partnership provides a robust set of digital assessments to help researchers better understand disease progression and enhance clinical trials in a historically challenging area of drug development.

Learn more in the full announcement: https://hubs.la/Q03xGd6s0

Combining real-world functional monitoring with audio-visual assessments addresses challenges with poor outcome measurements in neurology clinical trials.

07/16/2025

✨ The ADDS Basel 2025 Agenda is now available! ✨

The schedule includes leading digital health researchers from biopharma and academic research featuring their work in -

🔹Neurology and Oncology focused presentation sessions where digital health leaders share their lessons learned and new research findings using DHTs to advance R&D in these fields

🔹Technical Validation and Regulatory Pathways focused talks and panel discussions designed to share new opportunities, lessons learned, and foster discussion on how we can accelerate adoption of DHTs in regulated trials

🔹Scientific Poster Session focused on sharing the latest, unpublished research and applications of wearable technologies in clinical research - there is still time to submit your abstract by July 27th

🔹Networking breaks for attendees to open doors for interdisciplinary collaboration, innovative solutions, funding, and career opportunities

Space is limited; make sure to reserve your spot!

A special thank you to our event partner, CSEM, as well as all of our speakers and panelists!
Mathieu Lemay, Arne Müller, Dawid Gerstel, PhD, Aiden Doherty, Michael Pettinati, Asun Rubio, Rea Lehner, Eva Brack, Eitan Asher, Mike Domenik Rinderknecht, Dimitar Stanev, Claire Lugrin, Dzmitry Kaliukhovich, Lorcan Walsh, Ph.D., Jonas Dorn, Nikolay Manyakov, Christine Cong Guo, Sylvain Zorman, PhD

07/15/2025

Don’t miss our next Digital Health Monthly webinar ⏩ Grant Planning for Wearable-Based Research: Insights & Best Practices on July 30th!

We’ll discuss actionable insights and lessons learned along the spectrum from pre-study planning, to grant submission, to operationalizing your study, with time for audience Q&A.

We’ll also review new resources available from Ametris to help researchers better prepare for their grant applications that include actigraphy.

We’re looking forward to an insightful roundtable discussion featuring -
🔹Samuel Lamunion, PhD, Principal Consultant, LRS & C, LLC
🔹Catherine Lang, PT, PhD, FAPTA, Professor of Physical Therapy, Neurology & Occupational Therapy, Washington University in St. Louis
🔹Sriram Yennu, MD, MS, FAAHPM, Professor, Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center
🔹Hayden Davis, Senior Director of Public Health and Academia, Ametris
🔹Rakesh Pilkar, PhD, Lead DHT Solutions, Neuroscience, Ametris

Register today using the link in the comments! 👇